ScinoPharm Taiwan Receives Double Recognition for Sustainability

ScinoPharm Taiwan (TWSE: 1789) has been recognized with two honors in the 2026 CommonWealth Sustainability Awards, receiving 13th place in the Small Giants category of the Excellence in Corporate Social Responsibility Award and the CommonWealth Talent Sustainability Award. This marks the third consecutive year that ScinoPharm Taiwan has been recognized in the Small Giants category, reflecting the Company's continued efforts to advance sustainable development and talent cultivation.

Organized by CommonWealth Magazine, the Excellence in Corporate Social Responsibility Award is one of Taiwan's leading corporate sustainability awards. The award draws on international sustainability indicators and assessment methodologies and evaluates companies across four key dimensions: corporate governance, corporate commitment, social engagement, and environmental sustainability.

Since its establishment, ScinoPharm Taiwan has upheld integrity and sound governance as the foundation of its operations, embedding sustainability into its daily business practices. From risk management to regulatory compliance, the Company maintains rigorous standards to strengthen a culture of responsible and trusted corporate governance. In response to global climate change and environmental challenges, ScinoPharm Taiwan continues to implement initiatives in energy conservation and carbon reduction, waste reduction, and resource reuse, translating its sustainability commitments into concrete actions.

In the 2026 Excellence in Corporate Social Responsibility Award, ScinoPharm Taiwan ranked 13th in the Small Giants category, advancing two places from the previous year. The recognition reflects the Company's ongoing efforts to integrate sustainability into its business operations and long-term development.

The CommonWealth Talent Sustainability Award evaluates companies across six dimensions: compensation and rewards, talent investment and development, employee well-being and healthy workplaces, diversity, equity and inclusion, compliance with fundamental labor conditions, and workforce composition. ScinoPharm Taiwan places strong emphasis on employee well-being and provides comprehensive employee benefits, supported by a friendly workplace environment, compensation and benefits programs, internal career mobility opportunities, and structured training and development programs.

The Company also continues to respond to the diverse needs of its employees and foster a workplace that is diverse, equitable, supportive, and inclusive. Beyond the workplace, ScinoPharm Taiwan actively engages with local communities and participates in a range of social initiatives, extending its commitment to sustainability from pharmaceutical expertise to meaningful social engagement.

As a pharmaceutical company specializing in the development and manufacturing of high-barrier APIs and drug products, ScinoPharm Taiwan is committed to providing comprehensive integrated solutions. With a long-standing focus on global health and well-being, the Company regards sustainability as an integral part of its corporate development and continues to advance initiatives across corporate governance, environmental sustainability, and social inclusion.

These efforts reflect ScinoPharm Taiwan’s brand slogan: "For every life. With every trust." The Company believes that creating sustainable value requires a balanced approach that considers economic development, social responsibility, and environmental sustainability.

The dual recognition in the Excellence in Corporate Social Responsibility Award and CommonWealth Talent Sustainability Award serves as encouragement for ScinoPharm Taiwan's ongoing sustainability efforts. Looking ahead, the Company will continue to build on its pharmaceutical expertise, further advance ESG initiatives, and work together with employees, partners, and society to contribute to a healthier and more sustainable future.